As of 2026-02-18, the Relative Valuation of NOXXON Pharma NV (ALNOX.PA) is (3.94) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.05 EUR, the upside of NOXXON Pharma NV based on Relative Valuation is -7978.0%.
The range of the Relative Valuation is (5.84) - (2.12) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 11.6x | 9.9x |
| Forward P/E multiples | 32.0x - 34.6x | 33.3x |
| Fair Price | (5.84) - (2.12) | (3.94) |
| Upside | -11777.4% - -4343.0% | -7978.0% |
| Date | P/E |